Amoéba S.A.

Update in progress

ALMIB.PA (Paris)

Company RatingNeutral
SectorBasic Materials
IndustryAgricultural Inputs

Amoéba S.A. develops biological products and services to manage microbiological risk in water, health, and plant protection markets in France. The company uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky to treat water, surfaces, and chronic wounds, and also offers agricultural biocontrol products from lysed amoebae to combat phytopathogenic microorganisms. Founded in 2010, it is headquartered in Chassieu, France.

Company score

Sentiment: 0.42; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.32; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.19; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.13; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.19; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.31; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive